Switch to:
More From Other Websites
Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc.,... Jul 24 2017
Repros' Proellex Stays on Partial Clinical Hold, Shares Fall Jul 18 2017
INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Repros Therapeutics Inc. Jul 17 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics... Jul 17 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros... Jul 17 2017
Repros Announces Proellex® Development Program Will Remain on Partial Clinical Hold by the FDA Jul 17 2017
Repros Announces Pricing of $3.0 Million Public Offering Of Common Stock And Warrants To Purchase... May 18 2017
Repros Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock May 17 2017
Repros Therapeutics reports 1Q loss May 09 2017
Repros Therapeutics Inc.® Reports First Quarter 2017 Financial Results May 09 2017
What's in the Cards for Repros (RPRX) this Earnings Season? May 05 2017
Repros' Proellex Continues to be Under Partial Clinical Hold Apr 11 2017
Woodlands drug company names new top exec Apr 11 2017
Repros (RPRX) Q4 Earnings: What's in Store for the Stock? Mar 07 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK